ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND LINAGLIPTIN IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Seong, S. [1 ]
Kang, W. [1 ]
Ohk, B. [1 ]
Kim, B. [1 ]
Gwon, M. -R. [1 ]
Cho, S. [1 ]
Lee, H. [1 ]
Yoon, Y. -R. [1 ]
机构：
[1] Kyungpook Natl Univ, Hosp Clin Trial Ctr, Daegu, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-098
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] Assessment of the pharmacokinetic interaction between fimasartan and linagliptin in healthy volunteers
    Seong, S. J.
    Kang, W. Y.
    Ohk, B.
    Kim, B. K.
    Gwon, M. -R.
    Cho, S.
    Lee, H. W.
    Yoon, Y. -R.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S41 - S41
  • [2] A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
    Kang, Woo Youl
    Lee, Hae Won
    Gwon, Mi-Ri
    Cho, Seungil
    Shim, Wang-Seob
    Lee, Kyung-Tae
    Yang, Dong Heon
    Seong, Sook Jin
    Yoon, Young-Ran
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2101 - 2111
  • [3] PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND AMLODIPINE IN HEALTHY VOLUNTEERS
    Cha, Y.
    Yi, S.
    Gu, N.
    Yoon, S.
    Cho, J.
    Yu, K.
    Shin, S.
    Jang, I.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S91 - S91
  • [4] PHARMACOKINETIC INTERACTION BETWEEN A NOVEL ANGIOTENSIN II RECEPTOR BLOCKER, FIMASARTAN, AND HYDROCHLOROTHIAZIDE IN HEALTHY VOLUNTEERS.
    Kim, J. W.
    Kim, B. R.
    Shim, J. H.
    Yoon, S. H.
    Cho, J. Y.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S53 - S54
  • [5] LINAGLIPTIN HAS NO PHARMACOKINETIC INTERACTIONS WITH DIGOXIN IN HEALTHY VOLUNTEERS.
    Friedrich, C.
    Ring, A.
    Brand, T.
    Sennewald, R.
    Graefe-Mody, U.
    Woerle, H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S31 - S31
  • [6] Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
    Choi, Yewon
    Lee, SeungHwan
    Jang, In-Jin
    Yu, Kyung-Sang
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 2301 - 2309
  • [7] PHARMACOKINETIC INTERACTION BETWEEN ROSUVASTATIN AND FENOFIBRATE IN HEALTHY VOLUNTEERS.
    Yi, S.
    Kim, M.
    Han, S.
    Park, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S62 - S62
  • [8] Pharmacokinetic study on the interaction between cabergoline and clarithromycin in healthy volunteers.
    Nomura, T
    Zhang, J
    Nakatsuka, A
    Nomoto, M
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 74P - 74P
  • [9] Lack of pharmacokinetic interaction between morphine and dextromethorphan in healthy volunteers.
    Caruso, FS
    Johnson, DA
    Noonan, PK
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 122 - 122
  • [10] Assessment of pharmacokinetic interaction between aliskiren, a novel direct renin inhibitor, and metformin in healthy volunteers.
    Reynolds, C.
    Vaidyanathan, S.
    Dieterich, H. A.
    Yeh, C.
    Howard, D.
    Dole, W. P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S110 - S110
12345